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PolycombSystematic transcriptome analysis has revealed that a vastmajority of themammalian genome is transcribed into
RNA, thus establishing the concept of “pervasive transcription.”More than half of these RNAs do not encode pro-
teins, and they are collectively called noncoding RNAs. Although the physiological relevance of the transcription
of these noncoding RNAs has remained unclear, it was recently proposed that one of the major roles of long non-
coding RNAs (lncRNAs) in the nucleus is the regulation of gene expression at the transcriptional level via histone
or DNAmodiﬁcation. In this review, wewill summarize the advancement of our understanding of themolecular
mechanisms of lncRNAs. This article is part of a Special Issue entitled: Chromatin and epigenetic regulation of an-
imal development.
© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY license.1. Introduction
Since the term “transcriptome” was ﬁrst coined by Velculescu and
colleagues in 1997 [1], researchers have performed high-throughput
genome-wide analyses of gene expression using a variety of tissue and
cell types derived from higher organisms such as humans and mice
[2–9]. A primary ﬁnding of these large-scale transcriptome analyses is
that most of the mammalian genome is transcribed into RNAs, and the
number of genomic loci that produce nonprotein-coding (noncoding)
RNAs is comparable to or even higher than the number of loci that en-
code proteins [4,5,7–9], as conﬁrmed by the most recent edition of the
Encyclopedia of DNA Elements (ENCODE) [10]. Not clearly mentioned
in the literatures, these lncRNAs were sometimes considered as simple
transcriptional noise originating from regions of open chromatin or
even technical artifacts at the early days. Nevertheless, a series of inde-
pendent investigations on genetically identiﬁed classic lncRNAs such as
Xist [11] as well as RNA on the X1 (roX1) and 2 (roX2) [12] provided
compelling evidence that certain lncRNAs are involved in the epigenetic
regulation of gene expression. Following these studies, a number of
papers demonstrated that lncRNAs regulate gene expression through
associations with chromatin modifying complexes, as summarized in a
series of recent review articles [13–15].tin and epigenetic regulation of
81 48 467 4517.
. Open access under CC BY license.Comprehensive lists of functional lncRNAs are now available from
multiple web-based sources including lncRNAdb [16], NONCODE [17],
LncRNADisease [18], ncFANs [19], and LNCipedia [20], and daily news
on this topic can be found on the blog-style website “lncRNA blog”
(Table 1). The atmosphere surrounding the research ﬁeld of lncRNAs
has thus dramatically changed in recent years, although our under-
standing of the precise molecular mechanisms remains incomplete. In
this review, we will focus on lncRNAs that are localized to the nucleus,
and we will summarize the history of the emergence of the concept of
lncRNAs as transcriptional regulators.
2. General characteristics of pervasive transcription and lncRNAs
From the early days of transcriptome analysis, the expression of
lncRNAs has generally been recognized as being restricted to a small
set of tissues or cell types, and their expression levels are signiﬁcantly
lower than those of protein-coding transcripts [5]. This trend was con-
ﬁrmed by several studies, including systematic analyses in more recent
reports [21,22]. According to the most recent GENCODE v7 analyses,
lncRNAs have the following general properties compared with protein
coding mRNAs: shorter length, lower abundance, more restricted to
particular tissues or cells, and less frequently conserved between spe-
cies (Fig. 1) [22]. Another important characteristic is that lncRNAs are
more likely to be localized to the nucleus, suggesting that they may be
involved in certain nuclear processes such as gene expression control.
It is of note that the difference between the average expression levels
of mRNAs and lncRNAs is greater than two orders of magnitude, and
most lncRNAs are barely detectable (Fig. 1) [22], excluding a few abun-
dant nuclear lncRNAs that form nuclear bodies [23]. Therefore, the
classical assumption that most (estimated at 90%) RNA polymerase
II-transcribed products encode proteins remains essentially correct
Table 1
Websites for information on lncRNAs.
Name URL Reference
lncRNAdb http://www.lncrnadb.org/ [16]
NONCODE http://noncode.org/ [17]
lncRNADisease http://202.38.126.151/hmdd/html/tools/
lncrnadisease.html
[18]
ncFANs http://ebiomed.org/ncfans/ [19]
LNCipedia http://www.lncipedia.org/ [20]
lncRNA blog http://www.lncrnablog.com/
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asserts that most bases of the genome are associated with at least one
transcript in at least one cell type, has been proposed [25]. However,
this argument has been challenged by a recent study that reexamined
tiling arrays and deep-sequencing data [26]. These reexaminations
raised the possibility that most intergenic transcripts (including many
lncRNAs) are previously reported promoter- or terminator-associated
RNAs [27,28] and that the “genome is not as pervasively transcribed
as previously reported” [26]. A counterargument has been put forth
by other groups [29], and the current common consensus appears
to be thatmany “dark-matter” transcripts (if they exist) can be observed
only with exhaustive sampling and sufﬁcient sequencing depth (Fig. 1).Fig. 1. General characteristics of lncRNAs identiﬁed thorough transcriptome analyses. (A) Chara
the similar number of genomic loci encoding protein-coding genes (green) and lncRNAs (ma
deep-sequencing analysis. Note that the low expression of lncRNAs can be detected only when
expression pattern of protein-coding genes and lncRNAs in various tissues or cells. Protein-codin
expression. The expression of lncRNAs is more likely to be restricted to particular cell types.Whichever the case, most of the early transcriptome analyses were
only simple descriptions of lncRNAs, and it is clear that we have a
large list of lncRNAs with functions that remain to be experimentally
validated. What then is the function of lncRNAs that have thus far
been characterized?
3. Classic studies establishing the concept of lncRNAs as
transcriptional regulators
One of the ﬁrst lines of evidence suggesting that lncRNAs regulate
important biological processes came from genetic analyses of the
Drosophila bithorax complex during the 1980s, which led to the identi-
ﬁcation of lncRNAs from genetically identiﬁed functional elements [30].
The molecular functions and mechanisms of these lncRNAs have been
clariﬁed in detail [31]. In this case, the intergenic lncRNAs repress the
expression of neighboring genes in cis through transcriptional interfer-
ence [31]; transcription itself (but not the transcribed RNA) interferes
with downstreampromoter activities and thereby represses the expres-
sion of adjacent genes. A similar mechanism has been proposed for
SRG1 [32] and IME4 [33] in yeast and for Airn (originally designated
as Air: antisense to Igf2r RNA) in mice [34,35].
The second line of evidence came from genetic studies on sex
chromosome dosage compensation in mammals and Drosophila. Incteristic transcriptional output from the mammalian genome. “Gene organization” shows
genta). “Gene expression” shows a typical distribution of mapped reads obtained using
the analyses are performed with sufﬁcient depth (high-read analysis). (B) Characteristic
g genes are generally expressed in awide range of tissue or cells with signiﬁcantly greater
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equalize gene expression from the chromosome to that in males, who
have only oneX chromosome [36]. After theﬁrst description of this phe-
nomenon, referred to as X inactivation, in 1961, a series of genetic stud-
ies led to the seminal ﬁnding of an lncRNA named X-inactive speciﬁc
transcript (Xist) in 1991. Xist is expressed from the chromosomal region
that controls X inactivation [37,38]. Intriguingly, Xist does not encode
any proteins, and multiple copies of transcripts coat the entire length
of the inactive X chromosome [39]. Genetic evidence revealed that
Xist is necessary for X inactivation [40]. However, the molecular mech-
anism by which Xist controls gene expression remained unknown for
some time.
Subsequently, studies of X chromosome inactivation began to
converge into an independent research stream, the investigation of
the mechanism of general transcriptional regulation and histone
modiﬁcation. A series of studies revealed that repressive histone
marks and chromatin modiﬁers are enriched in the inactive X chromo-
some [41–44]. It was also demonstrated that mouse embryos with
mutant Eed (a component of the histone methyl transferase polycomb
repressive complex 2 [PRC2]) exhibit female-speciﬁc lethal phenotype
[45] characteristic of the failure of X chromosome inactivation. This
cytological and genetic evidence, together with biochemical evidence
illustrating the interaction betweenXist and PRC2 [46], led to thewidely
accepted current model in which Xist recruits the repressive chromatin
modiﬁer complex to the X chromosome (either directly or indirectly)
and silences gene expression at the chromosomal level [43].
In Drosophila, the single male X chromosome has 2-fold higher
expression than the female X chromosomes [47]. Impairment of this
system leads to male-speciﬁc lethal (msl) phenotypes, and several mu-
tants displaying the msl phenotypes including msl-1, msl-2, msl-3, and
malelesswere isolated. The gene products of these phenotypes comprise
the molecular complex called the MSL complex, which localizes to the
hyperactive male X chromosome [47]. The identiﬁcation of another
mslmutant,males absent on the ﬁrst (mof), greatly advanced the under-
standing of the molecular function of the MSL complex; mof encodes a
histone acetyltransferase, which is a catalytic subunit of the MSL
complex that regulates the acetylation of histone H4 in the male X
chromosome [48]. Subsequently, independent studies that utilized the
enhancer-trap strategy demonstrated that the lncRNAs roX1 and
roX2 are speciﬁcally expressed in males and localized on the male X
chromosome [49,50]. Genetic studies conﬁrmed that these lncRNAs
are required for proper localization of the MSL complex [51], and they
presumably function as a scaffold to assemble the MSL complex [12].
These studies also established the concept that lncRNAs function as
transcriptional regulators by associating with chromatin-modifying
complexes [12]. See also Larschan et al. in this issue for the detailed
review on the mechanisms of dosage compensation.
Third, research of the phenomenon called genomic imprinting
also identiﬁed lncRNAs that regulate the expression of neighboring
genes. Genomic imprinting was discovered by the nuclear transfer of
the paternal or maternal pronucleus into parthenogenetic mouse eggs
[52–54]. These experiments demonstrated that both paternal and
maternal genomes are necessary for normal development of the embry-
os, suggesting that the paternal andmaternal genomes are not identical
[52]. This ﬁnding suggested that certain genes are exclusively expressed
from either the paternal genome or the maternal genome, and subse-
quent efforts identiﬁed a number of genomic loci in which a cluster of
genes is expressed in an allele-speciﬁc manner. Careful examination of
such imprinted regions identiﬁed differentially methylated regions of
DNA [55,56] that are essential for the allele-speciﬁc gene expression
conﬁrmed by genetic analyses [57]. Subsequent intensive examination
of gene transcripts from imprinted regions identiﬁed lncRNAs that are
typically expressed from an antisense strand of imprinted genes that
encode proteins including Kcnq1 opposite strand antisense transcript
1 [58–60] andAirn [61]. Functional involvement of these antisense tran-
scripts in epigenetic genomic imprinting was conﬁrmed using a reversegenetic approach, and these transcripts were suggested to regulate the
expression of neighboring genes in a manner similar to that of Xist
[62]. Investigations of genetically identiﬁed loci also led to the identiﬁ-
cation of various antisense lncRNAs such as Tsix (antisense of Xist)
[63] cc RNA in the INK4 locus (ANRIL) [64,65]. Recent studies demon-
strated that lncRNAs involved in genomic imprinting regulate transcrip-
tion by associating with chromatin-modifying complexes such as
PRC1 and PRC2 [65–69] or through transcription interference [35]. See
also Weaver and Bartolomei in this issue for detailed review on the
regulators of genomic imprinting.
These classic studies provided compelling genetic evidence that
lncRNAs can function as cis- or trans-acting transcriptional regulators
that play important roles in a variety of biological phenomena. The
knowledge obtained by these studies accelerated the subsequent
functional analyses of lncRNAs that were recently identiﬁed through
high-throughput analyses.
4. Functional analyses of lncRNAs identiﬁed through
transcriptome analyses
Although early transcriptome analyses were designed to create a
complete list of lncRNAs expressed in certain tissues or cells, the semi-
nal functional analyses were performed for an lncRNA named Hox tran-
script antisense RNA (HOTAIR) [70]. The authors performed intensive
expression analyses of human HOX loci using tiling arrays, and these
analyses led to the identiﬁcation of multiple putative ncRNAs expressed
from the boundary between active and silent chromatin domains in-
cluding HOTAIR expressed from the HOXC cluster [70]. The authors
then depleted HOTAIR using siRNAs and examined the effects on global
gene expression using tiling arrays. Interestingly, HOTAIR depletion led
to the upregulation of genes located in the HOXD clusters, suggesting
that HOTAIR normally represses gene expression from theHOXDcluster
in trans. They also found that HOTAIR interacts with the components of
PRC2 in a distinct but similar manner (cis versus trans) to the classic
lncRNAs such as Xist. Subsequent studies from the same group revealed
that HOTAIR is dramatically upregulated in certain cancer cells and that
it regulates metastasis [71]. These studies also revealed that HOTAIR in-
teracts with at least two different chromatin modiﬁcation complexes
and functions as amolecular scaffold to assemble the epigenetic regula-
tors [72]. The success of these HOTAIR studies marked a turning point
at which transcriptome analyses met functional analyses, and many
researchers began to investigate the function of lncRNAs identiﬁed
through high-throughput analyses using siRNA technology.
The identiﬁcation of interacting proteins through a candidate-
molecule approach also became a standard analysis, and a number of
interactions between lncRNAs and chromatin modiﬁer complexes
have been conﬁrmed (primarily using RNA immunoprecipitation [RIP],
Table 2). The interactions were found to be consistent with themolecu-
lar model ﬁrst proposed for Xist. According to this model, lncRNAs
associate with chromatin modiﬁer complexes or proteins involved in
transcriptional regulation. The lncRNAs recruit these complexes and
proteins to the target site in either cis or trans and then up- or downreg-
ulate the expression of the target gene depending on the binding
partner proteins (Fig. 2). This model was further supported by the
large-scale identiﬁcation of lncRNAs that bind to PRC2, revealing that
a substantial fraction of lncRNAs associate with this complex [73,74].
We now have a growing list of nuclear lncRNAs involved in the tran-
scriptional regulation of gene expression including a set of activator
lncRNAs that possess enhancer-like activities [75], the cis-acting HOX
activators Hottip [76] and Mistral [77], a series of lincRNAs that control
ES cell differentiation [78], ANCR, which stabilizes the undifferentiated
state of progenitor cells in the epidermis [79], and Braveheart, which
controls the commitment of mesodermal cells in the cardiomyocyte
lineage [80]. Recently, forward and reverse genetic approaches were
also applied, leading to the ﬁnding of lncRNAs including DBE-T [81],
nettoie Salmonella pas Theiler's (NeST) [82], and Fetal-lethal noncoding
Table 2
Experimental evidence revealing the interactions of lncRNAs with gene regulatory proteins.
Gene Binds to Not binds to Methods Ref
Airn G9a n.a. CLIP (1% FA) [104]
ANRIL CBX7 n.a. CLIP (UV) [67]
Puriﬁed PRC1 n.a. EMSA [67]
Suz12 YY1 RIP [69]
Braveheart SUZ12, SNW1 RING1B, MLL, BRG1 RIP [80]
DBE-T Ash1l n.a. CLIP (UV) [81]
Fendrr Ezh2, Suz12, Wdr5 Ring1B, Lsd1, Sirt6 RIP [83]
HOTAIR SUZ12, EZH2 YY1 RIP [70]
EZH2, REST, CoREST, LSD1 G9a, CDYL, YY1 RNA pull-down [72]
EZH2, LSD1 n.a. CLIP (0.2% FA) [72]
Hottip Wdr5 Sirt6 RIP [76]
Kncq1ot1 G9a, EZH2, SUZ12 n.a. RIP [66]
Dnmt1 n.a. RIP [68]
LincRNAsa Ezh2, Suz12, Jarid1b, Ring1b a CLIP (1% FA) [78]
YY1, Jarid1C, Eset, Suv39h1
Cbx3, Setd8, Cbx1, Tip60/p400
HDAC1
Mistral MLL1 MENIN, LEDGF RIP [77]
MLL1 ASH1SET in vitro binding [77]
ncRNA-a MED1, MED12 n.a. RIP [105]
MED12 n.a. CLIP (UV) [105]
NeST Wdr5 n.a. RIP [82]
roX1/2 MOF RIP [106]
Tsix Dnmt3a H3 CLIP (1% FA) [107]
Xist Ezh2 n.a. RIP [46]
Puriﬁed PRC2 n.a. EMSA [46]
RIP: RNA immunoprecipitation under native conditions.
CLIP: Crosslinking and RNA immunoprecipitation under denaturing conditions.
EMSA: Electrophoretic mobility shift assay.
FA: formaldehyde, n.a.: not available.
a Seventy-ﬁve lincRNAs have been demonstrated to associate with chromatin-modifying complexes. Each lincRNA binds to a speciﬁc component of the complex with a unique afﬁnity.
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studies raised the intriguing possibility that many of the lncRNAs tran-
scribed from the genomemay regulate gene expression via associations
with chromatin modiﬁers.
In addition to the lncRNAs that regulate gene expression at the tran-
scriptional level, another group of lncRNAs accumulates abundantly
in the nucleus. Unlike typical lncRNAs, these lncRNAs are abundantly
expressed in levels comparable or even exceeding those of housekeep-
ing protein-coding genes such as glyceraldehyde-3-phosphate dehy-
drogenase or cytoskeletal β-actin. The nucleus is compartmentalizedFig. 2. Typical molecular mechanisms of the nuclear lncRNAs involved in the control of
gene expression.Widely acceptedmodels formolecular mechanisms of lncRNAs. lncRNAs
control target gene expression in a similar manner to general transcription factors by
recruiting chromatin-modifying complex to the target site. lncRNAs function as transcrip-
tional activators or repressors depending on the binding partner proteins.into speciﬁc nuclear bodies that contain speciﬁc sets of proteins
and nucleic acids. Some of the abundant nuclear lncRNAs, including
Malat1 in the nuclear speckles [84,85], Neat1 in the paraspeckles
[84,86–89], and Gomafu, which constitutes novel nuclear bodies in a
particular set of neurons [90], have been demonstrated to localize to
these nuclear bodies. The physiological function of these abundant
nuclear lncRNAs still remains largely unknown [23], and mice with
knockouts of these lncRNAs do not exhibit any apparent phenotypes
[91–94].
5. Issues to be considered for future functional analysis of lncRNAs
Although nuclear lncRNAs are recognized as major epigenetic regu-
lators, certain technical issues should be considered.Most of the current
lncRNA studies use siRNAs to deplete target lncRNAs in the nucleus.
However, RNAi may potentially induce transcriptional gene silencing
in mammalian cells, as has been established in ﬁssion yeast and plant
[95] (see also Cecere and Grishok in this issue). Although the presence
of such a nuclear RNA-induced silencing complex in mammalian cells
remains somewhat controversial, a series of experiments demonstrated
that siRNAs targeting the promoter region of particular genes induce
histone modiﬁcation in a manner dependent on AGO proteins and
function to either downregulate or activate the transcription of down-
stream genes [96–99]. These observations raise the possibility that
treatment with siRNA against certain lncRNAs directly induces changes
in epigenetic modiﬁcation independently of the endogenous function of
the target lncRNAs. Therefore, alternative loss-of function approaches
(which have currently been attempted only in a few cases) such as
classical homologous recombination to generate knockout animal
models will become important to fully conﬁrm the function of lncRNAs
and their physiological contributions in the epigenetic control of gene
expression [40,68,83,100,101]. In this regard, a recent effort to silence
the expression of target lncRNAs by integrating RNA-destabilizing
219S. Nakagawa, Y. Kageyama / Biochimica et Biophysica Acta 1839 (2014) 215–222elements using zinc ﬁnger nucleases is noteworthy and is a more
rapid and universal silencing approach applicable even for nonmodel
organisms [102].
6. Importance of genetic studies—forward and reverse genetic
analysis of lncRNAs
As previously mentioned, the initial evidence for functional lncRNAs
was primarily obtained in genetic studies, which have been rapidly
replaced byhigh-throughput technologies and rapid functional validation
using RNAi-mediated silencing approaches. However, genetic approaches
have recently been applied in several cases, and these approaches should
become increasingly important in the future.We summarize three repre-
sentative examples of these approaches as utilized in recently published
studies.
6.1. D4Z4 binding element transcripts (DBE-T)—hereditary disease-
associated lncRNA
DBE-T is a putative lncRNA that overlaps a portion of the D4Z4 re-
peats mapping to human 4q35 [81] and associates with the hereditary
disease facioscapulohumeral muscular dystrophy (FSHD). In patients
with FSHD, the copy number of D4Z4 repeats is reduced to less than
11 (normal range, 11–100), resulting in de-repression of the genes in
the 4q35 locus. To address the function of DBE-T transcribed from the
chromosomal region, the researchers developed a uniquemodel system
using human/rodent hybrid cell line that carries a single human chro-
mosome 4 in the CHO cell background [81]. Using this cell line, de-
repression of 4q35 found in the FSHD patients can be mimicked by the
treatment with 5-aza-2-deocycitidine (AZA) and trichostatin A (TSA),
which inhibit DNA methylation and histone de-acetylation, respective-
ly. Importantly, the de-repression of this locus upon the AZA/TSA
treatment is suppressed by the shRNA-mediated silencing of DBE-T.
Although the transcriptional start and termination sites of DBE-T are
not fully characterized, DBE-T associates with Ash1L, a component of
the TrxG/MLL complex, which induces active chromatin modiﬁcations.
The authors proposed a mode in which the reduction of D4Z4 induces
the expression of DBE-T, which then recruits TrxG to the 4q35 locus
and counteracts the repressive activity of PcG, thus de-repressing the
expression of the 4q35 locus. This is the ﬁrst example of lncRNAs tran-
scribed from genetic loci that are associated with hereditary diseases.
6.2. NeST—lncRNA derived from the gene locus affecting virus susceptibility
NeST has been identiﬁed as one of the genes located in the Theiler's
murine encephalitis virus persistence 3 locus, which controls suscepti-
bility to Theiler's virus, a picornavirus that grows in macrophages [82].
The expression of NeST is speciﬁcally upregulated in T cells derived
from a speciﬁc mouse strain that cannot clear the virus. Importantly,
the ability of transgenic mice to overexpress NeST and thus clear viral
infection is also compromised, resulting in viral persistence. Because
the transgene is inserted in a different chromosome of the endogenous
NeST locus, NeST is believed to act in trans. At the molecular
level, previous investigations demonstrated that NeST upregulates the
expression of interferon γ in T cells and increases active histone
marks such as H3K4me3. The authors also revealed that NeST is co-
immunoprecipitated by antibodies against WDR5, which is a subunit
of the MLL/SET1 H3K4 methylase complex. Their results suggested
that NeST recruits theMLL/SET1 complex to the target promoter regions
in trans, as has been proposed for the molecular action of Hottip. Inter-
estingly, the total amount of NeST in T cells is very low, estimated to be
0.15molecules per cell, which is similar to the abundance of Hottip (less
than 1 molecule per cell). NeST may be expressed only in a very limited
subset of T cells, or there may be a speciﬁc mechanism that enables a
single molecular complex to properly ﬁnd the target site to activate
gene expression.6.3. Fendrr—reverse-genetics meets lethal phenotype
Fendrr was originally identiﬁed using RNA-seq and ChIP-seq analy-
sis as a gene that is speciﬁcally expressed in the posterior mesoderm
of early mouse embryos [83]. Fendrr is located upstream of Foxf1,
a gene that regulates mesodermal differentiation [103]. Fendrr and
Foxf1 are co-expressed in the newly formed lateral plate mesoderm,
although Fendrr expression is downregulated as the tissue becomes
more differentiated. Fendrr loss-of-functionmutantmicewere generated
by replacing the ﬁrst exon with tandem polyadenylation signals, and ho-
mozygous mutant mice exhibited defects in the formation of the heart
and body wall, both of which arise from the lateral plate mesoderm,
resulting in embryonic lethality. Importantly, the phenotype is mostly
rescued by a BAC transgene containing Fendrr, suggesting that the effect
is not caused by nonspeciﬁc alternation of the chromatin structures prox-
imal to the gene-targeted region or by mutations in the ES cells used for
generating the knockoutmice. In the Fendrr mutantmice, the expression
ofmultiple genes involved in the differentiation of the lateral platemeso-
derm is upregulated in the affected tissue.
Histone modiﬁcation of the promoter of these genes is also altered,
reducing repressive histone marks such as H3K27me3 and concomi-
tantly increasing active histone marks such as H3K4me3, although the
effects are variable between the target genes. The authors of this analy-
sis also performed RIP using antibodies against the components of
the PRC2 and TrxG/MLL complexes and found that Fendrr binds to
both of these chromatin modiﬁcation complexes. The authors also
demonstrated that the synthetic ribonucleotide fragments of Fendrr
are crosslinked to the promoter sequence of the target genes in vitro.
The authors thus proposed that Fendrr recruits PRC2 and TrxG/MLL
complexes to the promoter regions of the target genes. Given that
these two complexes function to counteract gene transcription, Fendrr
should discriminate the binding partner depending on the target
genes. Themechanism of this activity remains to be investigated.What-
ever the mechanism, it should be noted that this is the ﬁrst example of
an lncRNA knockout mouse displaying embryonic lethal phenotypes
(excluding Xist mutant animals).7. Conclusions
What is the general function and mechanism of lncRNAs?
This frequently asked question is similar to asking, “What is the
general function of proteins?” Nevertheless, it should be noted that
a large number of lncRNAs have been revealed to interact with
chromatin-modifying complexes, and mounting evidence suggests
that the epigenetic control of gene expression is amajor role of lncRNAs
in addition to serving as precursors of small RNAs involved in RNA
silencing. When taken with the fact that the number of nonprotein-
coding regions in the genome appears to increase proportionally
with the complexity of the organisms (leaving aside how to quantitate
the value), it could be hypothesized that the expansion of lncRNA-
mediated epigenetic control of gene expression provided a basis for
the creation of extremely sophisticated organisms such as mammals
during evolution despite a comparable number of protein-coding
genes. Whatever the case is, we should be aware that the genetic and
biochemical evidence for the function of lncRNAs remains limited, and
multiple experimental approaches are essential to further investigate
this intriguing concept.Acknowledgement
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